Enhance Therapies

Lakewood, NJ Health careNAICS 621900

Self-funded health planPlan year 2025Renews January
3,498Participants0% vs. prior year
$8.3MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#9 of 53Health care in NJBy participants

Overview

Enhance Therapies sponsors a self-funded health plan that covered 3,498 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
3,498 · prior year 3,498
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Enhance Therapies Health and Welfare Benefit Plan, plan 501 (3,498 participants)
Stop-loss carrier
Sun Life Assurance Company of Canada
Broker compensation
$1.4M across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Sunlife Assurance Co. of CanadaDental, Vision, Short-term disability, Long-term disability1,688$2.6M$703K
Sun Life Assurance Company of CanadaStop-loss1,811$1.7M—
Continental American Insurance CompanyLife2,658$1.5M$746K
Metropolitan General Insurance CompanyLegal133$28K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$8.3M/ year

Estimated prescription spend: 3,498 participants × $2,371 national average per member. Usually higher once dependents are counted.

$216K–$532K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$63K–$158K
Lower-cost therapeutic alternatives$92K–$192K
Generic pricing vs. actual cost$40K–$119K
PBM contract terms$21K–$62K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Enhance Therapies
Sponsor EIN
88-2912580
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 88-2912580 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: Enhance Therapies's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Enhance Therapies.

Request a correction · Methodology